NON-EXCLUSIVE CABILLY PATENT LICENSE AGREEMENTCabilly Patent License Agreement • April 14th, 2010 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This Non-Exclusive Cabilly Patent License Agreement ("Agreement") is effective as of November 5, 2003 ("Effective Date") by and between Genentech, Inc., a Delaware corporation having its principal place of business at 1 DNA Way, South San Francisco, CA 94080 (hereinafter "Genentech") and Peregrine Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 14272 Franklin Ave, Suite 100, Tustin, CA 92780 (hereinafter "Licensee").
